Idera Pharmaceuticals (IDRA) Peer Comparison

$4.91

$-0.30 (-5.76%)

As on 17-Feb-2023 09:30EDT

Market cap

$27 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.8

Div. Yield

0 %

Edit

	Idera Pharmaceuticals (IDRA)	Gemini Therapeutics (GMTX)
Market cap ($ Mln)	27	58
Revenue ($ Mln)	0	--
Net Profit ($ Mln)	-16.70	-43.42
Net Margin (%)	-34,087.76	-8,666.87
RoE (%)	-71.67	-40.17
Price to Earnings	--	--
Price-To-Book	0.84	0.68

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Idera Pharmaceuticals (IDRA)	Gemini Therapeutics (GMTX)
Operating Revenue	0.00	0.00
Cost of Revenue	--	--
Gross Profit	--	--
Operating Expenses	27.67	69.00
Operating Profit (EBIT)	-27.67	-69.00
Other Income	0.14	--
Profit before Tax	98.09	-71.87
Provision for Tax	--	--
Profit after Tax (Net Income)	98.09	-71.87
Minority Interest	--	--
Consolidated Profit	96.94	-71.87

Liabilities ($ Mln)

	Idera Pharmaceuticals (IDRA)	Gemini Therapeutics (GMTX)
Shareholder's Funds	29.45	124.84
Minority Interest	--	--
Non-Current Liabilities	0.55	0.76
Current Liabilities	4.86	14.83
Total Liabilities	34.86	140.44

Assets ($ Mln)

	Idera Pharmaceuticals (IDRA)	Gemini Therapeutics (GMTX)
Non-Current Assets	0.83	0.34
Current Assets	34.04	140.10
Total Assets	34.86	140.44
Total Debt*	0.76	5.40
Net Current Assets	29.18	125.27

Cashflow ($ Mln)

	Idera Pharmaceuticals (IDRA)	Gemini Therapeutics (GMTX)
Cash From Operating Activities	-24.60	-59.70
Cash Flow from Investing Activities	4.50	0.34
Cash from Financing Activities	19.41	191.48
Net Cash Inflow / Outflow	-6.79	--

Ratios

Profitability Ratios

	Idera Pharmaceuticals (IDRA)	Gemini Therapeutics (GMTX)
ROCE (%)	-326.90	-58.07
ROE (%)	-317.86	-59.37
ROA (%)	253.91	-54.75
EBIT Margin (%)	--	--
Net Margin (%)	-82,235.04	--
Cash Profit Margin (%)	--	--

Growth Ratios

	Idera Pharmaceuticals (IDRA)	Gemini Therapeutics (GMTX)
Revenue Growth (%)	-1.00	--
EBIT Growth (%)	--	--
Net Profit Growth (%)	187.07	-8,745.47
EPS Growth (%)	--	--
Book Value Growth (%)	--	--

Valuation Ratios

	Idera Pharmaceuticals (IDRA)	Gemini Therapeutics (GMTX)
Price / Earnings	--	--
Price / Book Value	--	--
Dividend Yield (%)	--	--
EV/EBITDA	-0.32	1.89
Market Cap ($ Cr)	--	--

Solvency Ratios

	Idera Pharmaceuticals (IDRA)	Gemini Therapeutics (GMTX)
Debt to Equity	0.03	0.04
Short term debt to equity ratio	0.01	0.04
Current Ratio	7.00	9.44
Quick Ratio	--	--
Interest Coverage	14,014.00	-32.30

Operating Efficiency Ratios

	Idera Pharmaceuticals (IDRA)	Gemini Therapeutics (GMTX)
Debtors to sales (%)	--	--
Asset Turnover	0.00	0.00
Receivable days	--	--
Inventory Days	--	--
Payable days	--	--
Cash Conversion Cycle	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly